Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 4,929,000 | 5,243,000 | 4,922,000 | 4,871,000 | 4,391,000 |
| Cost of Goods | 1,265,000 | 1,406,000 | 1,305,000 | 1,206,000 | 1,052,000 |
| Gross Profit | 3,664,000 | 3,837,000 | 3,617,000 | 3,665,000 | 3,339,000 |
| Operating Expenses | 1,709,000 | 2,751,000 | 2,058,000 | 2,050,000 | 1,684,000 |
| Operating Income | 1,955,000 | 1,086,000 | 1,559,000 | 1,615,000 | 1,655,000 |
| Pre-tax Income | 1,955,000 | 1,086,000 | 1,559,000 | 1,615,000 | 1,655,000 |
| Income Tax | 429,000 | 188,000 | 344,000 | 427,000 | 449,000 |
| Net Income Continuous | 1,526,000 | 898,000 | 1,215,000 | 1,188,000 | 1,206,000 |
| Minority Interests | -48,000 | 4,000 | 13,000 | 22,000 | 11,000 |
| Net Income | $1,574,000 | $894,000 | $1,202,000 | $1,166,000 | $1,195,000 |
| EPS Basic Total Ops | 0.95 | 0.53 | 0.72 | 0.70 | 0.72 |
| EPS Basic Continuous Ops | 0.92 | 0.54 | 0.73 | 0.71 | 0.72 |
| EPS Diluted Total Ops | 0.94 | 0.53 | 0.72 | 0.69 | 0.71 |
| EPS Diluted Continuous Ops | 0.91 | 0.53 | 0.72 | 0.71 | 0.72 |
| EBITDA(a) | $2,148,000 | $1,208,000 | $1,664,000 | $1,705,000 | $1,720,000 |